Selectis Health Completes $15.7M Asset Sale, Securing $9M Net Proceeds Amidst Going Concern Doubts
summarizeSummary
Selectis Health, Inc. completed the sale of two skilled nursing facilities for $15.7 million, generating approximately $9 million in net proceeds, significantly boosting liquidity amidst ongoing financial concerns.
check_boxKey Events
-
Asset Disposition Completed
Selectis Health, Inc. completed the sale of two wholly-owned skilled nursing facilities, 'Glen Eagle Healthcare and Rehab' and 'Eastman Healthcare and Rehab', on May 1, 2026.
-
Significant Proceeds Received
The facilities were sold for an aggregate purchase price of $15.7 million. After payment of mortgage debt and other liabilities, the company received approximately $9 million in net proceeds at closing, with an additional $1.57 million held in escrow.
-
Addresses Liquidity Concerns
The $9 million net cash infusion is a substantial boost to the company's liquidity, which is critical given its previously reported 'going concern' doubts and material weakness in internal controls.
-
Follows Tender Offer Termination
This asset sale occurred on the same day (May 1, 2026) that Black Pearl Equities terminated its tender offer to acquire Selectis Health shares, making the proceeds a timely and important source of capital.
auto_awesomeAnalysis
This filing reports the completion of a significant asset disposition for Selectis Health, Inc., which is highly material given the company's small market capitalization and previously disclosed 'going concern' doubts. The $9 million in net proceeds provides a critical liquidity injection, potentially alleviating immediate financial pressures and extending the company's operational runway. This cash infusion is particularly important as it follows the termination of a tender offer on the same day, making the asset sale a crucial source of capital. While the sale of two skilled nursing facilities reduces the company's asset base, the immediate benefit of improved liquidity in a distressed financial situation is a notable development for investors.
At the time of this filing, GBCS was trading at $3.50 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $10.7M. The 52-week trading range was $0.41 to $6.25. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.